Cyclo Therapeutics, Inc.

CYTH · NASDAQ
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Operating Activities
Net Income-$9-$6-$4-$6
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$0
Stock-Based Comp.-$0$0$0$0
Change in WC$1$1-$2$1
Other Non-Cash-$0$1$2$0
Operating Cash Flow-$8-$4-$6-$4
Investing Activities
PP&E Inv.-$4$4$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0-$0
Investing Cash Flow$0$0$0-$0
Financing Activities
Debt Repay.$8$0$0$0
Stock Issued$0$0$0$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$2-$0$11
Financing Cash Flow$8$2-$0$12
Forex Effect$0$0$0$0
Net Chg. in Cash-$0-$2-$6$7
Supplemental Information
Beg. Cash$1$3$9$2
End Cash$1$1$3$9
Free Cash Flow-$12-$4-$6-$4
Cyclo Therapeutics, Inc. (CYTH) Financial Statements & Key Stats | AlphaPilot